Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Hipertens Riesgo Vasc ; 39(2): 62-68, 2022.
Artigo em Espanhol | MEDLINE | ID: mdl-35305932

RESUMO

INTRODUCTION: Hypertension (HTN) is the leading cause of mortality and disability in the world. In Argentina, almost 44% of hypertensives do not know about their condition and this may be due to the low rate of blood pressure (BP) measurements during the office visit. Our hypothesis is that the measurement and electronic recording of BP (BPMR) is not a routine practice in Argentina. OBJECTIVE: To describe the rate of office BP measurement in Argentina. METHODS: This is a retrospective, multicentre, point prevalence study. We analysed all office visits on 9/19/2019 at 9 medical institutions in 6 provinces of Argentina. RESULTS: Two thousand and eighty-two office visits were analysed. The patients' mean age was 52.1 years (18-103), 1790 (59.7%) were female, and 702 (36.1%) were hypertensives. BP was measured in 420 visits (14.1%; 95% CI 12.8-15.4). In a multivariate logistic regression model, history of HTN (OR 1.91, P<.001) and previous cardiovascular event (OR 1.76, P<.001) were associated with more odds of BPMR. The presence of cancer was associated with fewer odds of BPMR (OR .51, P<.01). Cardiology measured BP up to 49.5% (144/291 visits), followed by internal medicine 30% (152/507 visits). CONCLUSION: BPMR during office visits is deficient in Argentina and represents a missed healthcare opportunity. Different strategies are needed to detect hypertensive patients and reduce cardiovascular events.


Assuntos
Determinação da Pressão Arterial , Hipertensão , Pressão Sanguínea , Monitorização Ambulatorial da Pressão Arterial , Feminino , Humanos , Hipertensão/complicações , Hipertensão/diagnóstico , Hipertensão/epidemiologia , Masculino , Pessoa de Meia-Idade , Sistema de Registros , Estudos Retrospectivos
2.
Rev Esp Quimioter ; 32(5): 410-425, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31507152

RESUMO

Due to the rise in the number and types of immunosuppressed patients, invasive fungal infections (IFI) are an increasing and major cause of morbidity and mortality in immunocompromised adults and children. There is a broad group of pediatric patients at risk for IFI in whom primary and/or secondary antifungal prophylaxis (AFP) should be considered despite scant evidence. Pediatric groups at risk for IFI includes extremely premature infants in some settings, while in high-risk children with cancer receiving chemotherapy or undergoing haematopoietic stem cell transplantation (HCT), AFP against yeast and moulds is usually recommended. For solid organ transplanted, children, prophylaxis depends on the type of transplant and associated risk factors. In children with primary or acquired immunodeficiency such as HIV or long-term immunosuppressive treatment, AFP depends on the type of immunodeficiency and the degree of immunosuppression. Chronic granulomatous disease is associated with a particular high-risk of IFI and anti-mould prophylaxis is always indicated. In contrast, AFP is not generally recommended in children with long stay in intensive care units. The choice of AFP is limited by the approval of antifungal agents in different age groups and by their pharmacokinetics characteristics. This document aims to review current available information on AFP in children and to provide a comprehensive proposal for each type of patient.


Assuntos
Antifúngicos/uso terapêutico , Hospedeiro Imunocomprometido , Infecções Fúngicas Invasivas/prevenção & controle , Prevenção Primária/métodos , Prevenção Secundária/métodos , Candidíase/prevenção & controle , Criança , Monitoramento de Medicamentos , Infecções por HIV/complicações , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Humanos , Síndromes de Imunodeficiência/complicações , Terapia de Imunossupressão/efeitos adversos , Lactente Extremamente Prematuro , Recém-Nascido , Unidades de Terapia Intensiva Pediátrica , Neoplasias/tratamento farmacológico , Pneumonia por Pneumocystis/prevenção & controle , Fatores de Risco , Transplantados
3.
Scand J Immunol ; 86(3): 171-178, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29083052

RESUMO

Common variable immunodeficiency (CVID) is a syndrome with predominantly defective B cell function. However, abnormalities in the number and function of other lymphocyte subpopulations in peripheral blood (PB) have been described in most patients. We have analysed the distribution of iNKT cell subpopulations in the PB of CVID patients and the ability of these cells to provide in vitro cognate B cell help. The total of iNKT cells was reduced in the PB of CVID patients, especially CD4+, CD4-/CD8- and CCR5+/CXCR3+. These findings were associated with an enrichment of memory-like and a tendency towards a reduction in TNF-α-expressing effector iNKT cells in the peripheral blood mononuclear cells (PBMC) of CVID patients. Moreover, an accumulation of follicular helper iNKT cells in the PB of CVID patients was demonstrated. CVID αGalCer-pulsed iNKT cells are not able to induce autologous B cell proliferation although they do induce proliferation to healthy donor B cells. Interestingly, autologous and heterologous co-cultures did not differ in the amount of immunoglobulin secreted by B cells in vitro. Finally, reduced intracellular SAP expression in iNKT cells and other lymphocytes in the blood from CVID patients was observed. These results provide further insights into the immunological mechanisms underlying the iNKT cell defects and the potential targets to improve B cell help in CVID.


Assuntos
Linfócitos B/imunologia , Comunicação Celular , Imunodeficiência de Variável Comum/imunologia , Células T Matadoras Naturais/imunologia , Saposinas/metabolismo , Adolescente , Adulto , Antígenos CD4/metabolismo , Antígenos CD8/metabolismo , Proliferação de Células , Células Cultivadas , Técnicas de Cocultura , Feminino , Galactosilceramidas/imunologia , Humanos , Imunoglobulinas/metabolismo , Memória Imunológica , Ativação Linfocitária , Masculino , Pessoa de Meia-Idade , Receptores CCR5/metabolismo , Receptores CXCR3/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Adulto Jovem
4.
Int J Impot Res ; 22(4): 211-9, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20410903

RESUMO

Vacuum therapy (VT) utilizes negative pressure to distend the corporal sinusoids and to increase the blood inflow to the penis. Depending on its purpose, VT could be used as vacuum constriction device (VCD), with the aid of an external constricting ring which is placed at the base of penis to prevent blood outflow, maintaining the erection for sexual intercourse. Also, as a vacuum erectile device (VED), without the application of a constriction ring, just increases blood oxygenation to the corpora cavernosa and for other purposes. The emerging of phosphodiesterase 5 inhibitors (PDE(5)I) for the treatment of erectile dysfunction (ED) eclipsed VCD as therapeutic choice for ED; however, widespread usage of VED as part of penile rehabilitation after radical prostatectomy and other purposes rekindle the interest for VT. The underlying hypothesis is that the artificial induction of erections shortly after surgery facilitates tissue oxygenation, reducing cavernosal fibrosis in the absence of nocturnal erections, and potentially increases the likelihood of preserving erectile function. Due to its ability to draw blood into the penis regardless of nerve disturbance, VED has become the centerpiece of penile rehabilitation protocols. Herein, we reviewed the history, mechanism, application, side effects and future direction of VT in ED.


Assuntos
Disfunção Erétil/terapia , Coito , Contraindicações , Humanos , Masculino , Ereção Peniana , Pênis/irrigação sanguínea , Inibidores da Fosfodiesterase 5 , Inibidores de Fosfodiesterase/efeitos adversos , Inibidores de Fosfodiesterase/uso terapêutico , Prostatectomia/reabilitação , Ensaios Clínicos Controlados Aleatórios como Assunto , Vácuo , Vasodilatação
5.
Surg Laparosc Endosc ; 2(2): 148-51, 1992 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1341525

RESUMO

Fecal stream diversion is not an uncommonly used procedure in the treatment of symptomatic Crohn's disease of the rectum. We present a case report of a patient with documented Crohn's proctitis with multiple rectovaginal and perianal fistulas; an end sigmoid colostomy was performed as part of the management of her disease.


Assuntos
Colostomia/métodos , Doença de Crohn/cirurgia , Laparoscopia/métodos , Adulto , Doença de Crohn/complicações , Feminino , Humanos , Proctite/etiologia , Proctite/cirurgia , Fístula Retal/etiologia , Fístula Retal/cirurgia
6.
Rev. bras. anestesiol ; 39(6): 419-21, nov.-dez. 1989. ilus, tab
Artigo em Português | LILACS | ID: lil-80654

RESUMO

Vinte e cinco crianças de seis a 60 meses de idade foram submetidas a anestesia com halotano ou isoflurano mais succinilcolina e intubaçäo orotraqueal. Foram registradas as freqüencias cardíacas imediatamente a induçäo, imediatamente antes da punçäo venosa; trinta segundos após a injeçäo de succinilcolina; imediatamente após a intubaçäo orotraqueal. O aparecimento de arritmias era registrado no momento da ocorrência. A partir da induçäo, as freqüências cardíacas entre os dois grupos se diferenciaram a níveis estatisticamente significativos. Essa diferença foi principalmente devida a reduçäo no número de batimentos cardíacos nos pacientes submetidos a anestesia com halotano e acentuada com a intubaçäo orotraqueal. Embora o número de arritmias fosse maior no grupo que recebeu halotano, essa diferença näo foi estatisticamente significativa


Assuntos
Lactente , Pré-Escolar , Humanos , Feminino , Frequência Cardíaca , Halotano , Isoflurano , Succinilcolina , Intubação Intratraqueal
8.
Surg Gynecol Obstet ; 147(4): 497-502, 1978 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-705567

RESUMO

We have concluded from these observations in this pilot study that preoperative radiation therapy does not play a particularly helpful role in the management of patients who have the clinical finding of borderline operable carcinoma of the breast and it does not improve the survival rate. Patients within this category of locally advanced disease must be considered to have systemic metastatic disease at the time of diagnosis, as has previously been stressed by many. For this reason, any therapy directed to the regional area for local control must be combined with some form of systemic therapy if there is to be any hope for an increase in survival time.


Assuntos
Neoplasias da Mama/radioterapia , Adulto , Idoso , Neoplasias da Mama/patologia , Neoplasias da Mama/cirurgia , Feminino , Seguimentos , Humanos , Mastectomia , Pessoa de Meia-Idade , Metástase Neoplásica , Recidiva Local de Neoplasia , Projetos Piloto , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA